rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Sopheon Terug naar discussie overzicht

Sopheon mei 2020

28 Posts
Pagina: 1 2 »» | Laatste | Omlaag ↓
  3. Gartje 3 mei 2020 08:57

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    Wij ook fopje, op andere sites hebben ze het over een top van 9.33 de komende 8 weken, we gaan het zien!
  5. Bertus S 15 mei 2020 08:17

    • Bertus S

      Lid sinds: 03 aug 2002

      Laatste bezoek: 19 feb 2024

    • Aanbevelingen

      Ontvangen: 4534

      Gegeven: 3919

    •    Aantal posts: 27.083

    AGM Notice and Update

    Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, has published its Annual General Meeting (“AGM”) notice which is now available on the Company’s website, and will be posted to registered Shareholders today. The AGM will be held at 11 am on 11 June 2020, at the Company’s registered office. Given the Coronavirus situation, Shareholders are not expected to attend the meeting in person, and are encouraged to submit a proxy vote in accordance with the instructions in the notice. Arrangements have been made to ensure a quorum at the meeting. The Board takes this opportunity to give shareholders the following update and review of the business.

    2019 in review

    2019 benefited from the strong operational discipline in our business that enabled us to deliver a profitable and cash generative year, and despite a pause in revenue growth, we reported closing net asset and cash positions at historic highs. Consistent with our expectations, after a slow first half, momentum rebounded sharply in the final quarter of last year, which was one of the strongest on record for deal flow. Furthermore, we ended 2019 with a substantially larger sales pipeline, up 50% year on year. While we saw some signs of customer hesitation due to economic factors, we did not attribute this as a key issue prior to the incidence of the recent pandemic. Indeed, behind the headline financials, we signed the same number of new customers (18) in 2019 as in the year before. Today, our pipeline remains at a similar level to the year end, and the proportion of software as a service (“SaaS”) opportunities in the pipeline also remains high, especially from potential new customers. We first referred to this shift to SaaS in our 2018 annual report, and since then transformation to a cloud business has become a key internal driver of change. We have revised our standard pricing models, service delivery models and commission plans, and a longer-term migration of the software platform is underway. Experience tells us that the full conversion to SaaS will take several years.

    COVID-19

    The COVID-19 pandemic means that every organization is facing new and immediate challenges and opportunities that require urgent, strategic and effective responses. In terms of our own operations, we took early action to ensure the health and safety of staff, introducing an immediate work from home policy supported by well-defined virtual working practices, and we also assured continuity of business operations and cloud services through our co-location and Azure based infrastructure. This has all gone smoothly. For many of our customers, our Accolade solution offers visibility and speed to decisions in such times of crisis. Further to this point, during April we developed and launched an Accolade software configuration, the Disruption Response Toolkit, to enable our customers to rapidly develop their COVID-19 responses through quick assessment, analysis and reprioritization of strategic initiatives, and to implement changes to their supply chain or revisit their product portfolio strategy. In addition, a Microsoft® Teams Connector was announced which allows Accolade users to initiate a Teams call, chat or group discussion, all from within the Accolade platform. These offerings are being made available to existing customers at limited charge. They are designed to add value to their Accolade investment in a time of crisis, and to raise the profile of our solution to extended use cases to drive user growth.

    Outlook

    Clearly the market environment is tough, and though we are busy with several deals and we are signing business, sales cycles are extending. Projecting the impact that COVID-19 will have on customer conversion makes forecasting the future challenging, and we are therefore being prudent by withdrawing our market guidance for FY 2020 and beyond. However, several vertical markets where Sopheon operates – food, beverage and consumables; chemicals; defense – are showing resilience to the crisis at present. In addition, so far this year retention levels for ARR have remained good, and as noted we are seeing orders restart from our existing customers, as their own operations settle down. Visibility for the full year 2020 now stands at $23.2m, which is above last year at this time, underpinned by ARR at $15.9m. Net cash at the end of April was $21.8m. A moderate rise in cash is normal at this time of year, given our billing seasonality, but this clearly demonstrates the robustness of the Company’s balance sheet. We are nevertheless taking some measures to limit expenditure, including putting a temporary hold on the majority of our hiring plans for the second quarter. All these factors give us the confidence to proceed with our strategy under a range of disruption scenarios, which we have stress tested in detail. In this respect we have also concluded that we have sufficient strength and optimism to proceed with our declared dividend of 3.25p per share, and this is proposed to shareholders in the notice issued today, in line with the timetable set out in the final results.

    For Further Information Contact:

    Barry Mence, Chairman
    Arif Karimjee, CFO Sopheon plc + 44 (0) 1276 919 560

    www.sopheon.com/agm-notice-and-update...

    Bertus S.
  8. Arie de Beuker 15 mei 2020 15:21

    • Arie de Beuker

      Lid sinds: 17 mrt 2005

      Laatste bezoek: 02 feb 2025

    • Aanbevelingen

      Ontvangen: 212

      Gegeven: 545

    •    Aantal posts: 1.436

    Dank Bertus, er moet nog wat geburen om de 35 kk omzet te behalen hoor. Ik denk dat bedrijven toch investeringen uitstellen. Ik ben iig niet zo positief. Er zijn altijd bedrijven die wel goed draaien, dat dan weer wel.

    Gr
    Arie de Beuker
  9. Gartje 15 mei 2020 16:36

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    Gezien de toestand in de wereld mogen we tevreden zijn met deze update, dividend netjes op de rekening zodat we weer een keer naar de Chinees kunnen;-))
  10. Arie de Beuker 15 mei 2020 19:02

    • Arie de Beuker

      Lid sinds: 17 mrt 2005

      Laatste bezoek: 02 feb 2025

    • Aanbevelingen

      Ontvangen: 212

      Gegeven: 545

    •    Aantal posts: 1.436

    Met zoveel cash maar 3,5p is erg karig. Aan de andere kant wat zijn ze van plan met het geld? Over een paar jaar superdividend? Ze kunnen in ieder geval tegen een stootje.

    Gr
    Arie de Beuker
  12. [verwijderd] 15 mei 2020 19:33

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Ben redelijk tevreden hoor met deze update
    Zijn bizarre tijden. Hoogte dividend vind ik prima, zijn zat bedrijven die het dividend annuleren. Tegelijk nog aardig cash over voor "mogelijkheden"
  18. OVI 19 mei 2020 11:03

    • OVI

      Lid sinds: 16 mrt 2004

      Laatste bezoek: 18 dec 2024

    • Aanbevelingen

      Ontvangen: 103

      Gegeven: 267

    •    Aantal posts: 766

    is mijn porto ineens 20K minder!!!!! Moest wel even slikken.... SLIK

    hopelijk echt een foutje ;-)
    gr. OVI
  20. Gartje 19 mei 2020 11:52

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    Laten we het hopen Bertus, heb eigenlijk al genoeg mee gemaakt met Sopheon, wordt tijd dat we weer eens de goede kant op gaan met de koers!
  21. Bertus S 19 mei 2020 12:12

    • Bertus S

      Lid sinds: 03 aug 2002

      Laatste bezoek: 19 feb 2024

    • Aanbevelingen

      Ontvangen: 4534

      Gegeven: 3919

    •    Aantal posts: 27.083

    Wordt langzaamaan idd de hoogste tijd, anders worden we mogelijk pas postuum rijk en dat is nou nét niet de bedoeling...............................toch??

    Bertus S.
28 Posts
Pagina: 1 2 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 6.997
AB InBev 2 5.479
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.123
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.450
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.623
Aedifica 3 900
Aegon 3.258 322.602
AFC Ajax 537 7.084
Affimed NV 2 6.287
ageas 5.844 109.883
Agfa-Gevaert 14 2.046
Ahold 3.538 74.287
Air France - KLM 1.025 34.973
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.020
Alfen 16 24.234
Allfunds Group 4 1.468
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 403
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.806
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.834 242.589
AMG 971 133.002
AMS 3 73
Amsterdam Commodities 305 6.685
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 481
Antonov 22.632 153.605
Aperam 92 14.886
Apollo Alternative Assets 1 17
Apple 5 375
Arcadis 252 8.731
Arcelor Mittal 2.033 320.447
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.282
Aroundtown SA 1 219
Arrowhead Research 5 9.715
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.061
ASML 1.766 105.375
ASR Nederland 21 4.450
ATAI Life Sciences 1 7
Atenor Group 1 466
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.581
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.383